Search results
Results From The WOW.Com Content Network
Vasopressin V1b receptor (V1BR) also known as vasopressin 3 receptor (VPR3) or antidiuretic hormone receptor 1B is a protein that in humans is encoded by the AVPR1B (arginine vasopressin receptor 1B) gene. V1BR acts as a receptor for vasopressin. AVPR1B belongs to the subfamily of G protein-coupled receptors.
The human V 3 receptor (V 3 R, previously known as V 1B R) is a G-protein-coupled pituitary receptor that, because of its scarcity, was only recently characterized. [1] The 424-amino-acid sequence of the V 3 R has homologies of 45%, 39%, and 45% with the V 1 R, V 2 R and oxytocin receptor (OTR), respectively.
551 11998 Ensembl ENSG00000101200 ENSMUSG00000037727 UniProt P01185 P35455 RefSeq (mRNA) NM_000490 NM_009732 RefSeq (protein) NP_000481 NP_033862 Location (UCSC) Chr 20: 3.08 – 3.08 Mb Chr 2: 130.42 – 130.42 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Human vasopressin, also called antidiuretic hormone (ADH), arginine vasopressin (AVP) or argipressin, is a hormone synthesized ...
Also, unlike vasopressin 1b receptor and oxytocin knockout mice, AVPR1A knockout mice have a normal Bruce effect (appropriate failure of pregnancy in presence of novel male). [ 17 ] Although activation of AVPR1A is a major mediator of anxiogenesis in males, it is not in females.
Hypocretin (orexin) receptor 2 (HCRTR2, OX2R) Vasopressin receptor InterPro: IPR001817. Arginine vasopressin receptor 1A (AVPR1A, V1AR) Arginine vasopressin receptor 1B (AVPR1B, V1BR) Arginine vasopressin receptor 2 (AVPR2, V2R) Oxytocin receptor ; Gonadotropin releasing hormone receptor (GNRHR, GRHR) InterPro: IPR001658
Vasopressin agonists are used therapeutically in various conditions, and its long-acting synthetic analogue desmopressin is used in conditions featuring low vasopressin secretion, as well as for control of bleeding (in some forms of von Willebrand disease and in mild haemophilia A) and in extreme cases of bedwetting by children.
These receptors also cause a renal vasodilation, resulting in increased diuresis. This decreases the blood volume, resulting in the decrease of blood pressure. [ 2 ] [ disputed – discuss ] There are two types, type A is activated by atrial wall tension in atrial contraction (during the a wave of the atrial pressure curve), type B is activated ...
Conivaptan, sold under the brand name Vaprisol, is a non-peptide inhibitor of the receptor for anti-diuretic hormone, also called vasopressin. It was approved in 2004 for hyponatremia (low blood sodium levels). The compound was discovered by Astellas and marked in 2006. The drug is now marketed by Cumberland Pharmaceuticals, Inc.